US Patent 7220824 Integrin-mediated drug targeting
Patent 7220824 was granted and assigned to Bayer on May, 2007 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 7220824 Integrin-mediated drug targeting
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
